Ph. Leger
Stanford University
38 Papers
292 Citations
Ph. Leger is an academic researcher from Stanford University. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 11, co-authored 38 publications.
Chat about Author
Papers
Peripheral extracorporeal membrane oxygenation (ECMO) in patients with posttransplant cardiac graft failure.
P. Leprince,Stéphane Aubert,Nicolas Bonnet,Rama A,Ph. Leger,Valeria Bors,Levasseur Jp,Jacques Szefner,E. Vaissier,Alain Pavie,Iradj Gandjbakhch +10 more
- 01 Jul 2005
TL;DR: Fast operating room or bedside implantation of a peripheral ECMO allows the physician to stabilize the hemodynamic status of patients with cardiac graft failure, potentially leading toward myocardial recovery.
51
Expanded polytetrafluoroethylene membranes to wrap surfaces of circulatory support devices in patients undergoing bridge to heart transplantation
P. Leprince,M. Rahmati,Nicolas Bonnet,Valeria Bors,Rama A,Ph. Leger,Iradj Gandjbakhch,Alain Pavie +7 more
TL;DR: Use of ePTFE membranes in patients undergoing bridge to transplantation with either an LVAD or a TAH limited adhesions between tissues and device surfaces without increasing the risk of infection.
•Journal Article
Heterotopic heart transplantation: current status in 1988.
M. Desruennes,Claudio Muneretto,Gandjbakhch I,Akira Kawaguchi,Alain Pavie,Bors,C. Piazza,G. Rabago,Ph. Leger,Vaissier E +9 more
TL;DR: HHT does not seem to improve the prognosis of patients with elevated PVR and is still indicated in large patients and in emergency situations in which an available donor heart appears unable to support the recipient's circulation if used in the orthotopic position.
30
Total artificial heart: survival and complications.
Claudio Muneretto,E. Solis,Alain Pavie,Ph. Leger,Iradj Gandjbakhch,Jacques Szefner,Valeria Bors,C. Piazza,Cabrol A,C. Cabrol +9 more
TL;DR: All patients receiving the total artificial heart for severe acute rejection after transplantation died of infection, and the rate of complications were similar in the two Jarvik-7 groups.
26
•Journal Article
Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
Rottembourg J,Mattei Mf,Cabrol A,Ph. Leger,B. Aupetit,Beaufils H,Gluckman Jc,Alain Pavie,Gandjbakhch I,Cabrol C +9 more
TL;DR: The renal function and blood pressure of patients operated on in the department where cyclosporine was introduced in 1981 are analyzed to define the limits of its utility as a drug for long term immunosuppression.
23